CTIC Annual Net Income
-$92.99 M
+$4.92 M+5.02%
31 December 2022
Summary:
As of February 5, 2025, CTIC annual net profit is -$92.99 million, with the most recent change of +$4.92 million (+5.02%) on December 31, 2022. During the last 3 years, it has fallen by -$52.97 million (-132.36%).CTIC Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CTIC Quarterly Net Income
-$13.42 M
+$4.04 M+23.12%
31 March 2023
Summary:
As of February 5, 2025, CTIC quarterly net profit is -$13.42 million, with the most recent change of +$4.04 million (+23.12%) on March 31, 2023. Over the past year, it has increased by +$23.75 million (+63.90%).CTIC Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CTIC TTM Net Income
-$69.24 M
+$23.75 M+25.54%
31 March 2023
Summary:
As of February 5, 2025, CTIC TTM net profit is -$69.24 million, with the most recent change of +$23.75 million (+25.54%) on March 31, 2023. Over the past year, it has increased by +$48.58 million (+41.23%).CTIC TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CTIC Net Income Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +5.0% | +63.9% | +41.2% |
3 y3 years | -132.4% | -10.1% | -67.3% |
5 y5 years | -128.7% | -233.8% | -73.0% |
CTIC Net Income High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | ||||||
5 y | 5-year | ||||||
alltime | all time | +569.0% | -144.0% | +1136.4% |
CTI BioPharma Net Income History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2023 | - | -$13.42 M(-23.1%) | -$69.24 M(-25.5%) |
Dec 2022 | -$92.99 M(-5.0%) | -$17.46 M(+11.2%) | -$92.99 M(-17.2%) |
Sept 2022 | - | -$15.71 M(-30.7%) | -$112.32 M(-7.0%) |
June 2022 | - | -$22.65 M(-39.1%) | -$120.80 M(+2.5%) |
Mar 2022 | - | -$37.17 M(+1.1%) | -$117.82 M(+20.3%) |
Dec 2021 | -$97.91 M(+86.7%) | -$36.79 M(+52.1%) | -$97.91 M(+28.6%) |
Sept 2021 | - | -$24.18 M(+22.9%) | -$76.12 M(+20.4%) |
June 2021 | - | -$19.68 M(+14.0%) | -$63.21 M(+9.9%) |
Mar 2021 | - | -$17.27 M(+15.1%) | -$57.53 M(+9.7%) |
Dec 2020 | -$52.45 M(+31.1%) | -$15.00 M(+33.2%) | -$52.45 M(+14.9%) |
Sept 2020 | - | -$11.26 M(-19.6%) | -$45.64 M(+2.7%) |
June 2020 | - | -$14.00 M(+14.9%) | -$44.42 M(+7.3%) |
Mar 2020 | - | -$12.19 M(+48.8%) | -$41.39 M(+3.4%) |
Dec 2019 | -$40.02 M(+36.5%) | -$8.19 M(-18.5%) | -$40.02 M(+29.2%) |
Sept 2019 | - | -$10.05 M(-8.4%) | -$30.99 M(-13.3%) |
June 2019 | - | -$10.97 M(+1.5%) | -$35.75 M(-1.0%) |
Mar 2019 | - | -$10.81 M(-1378.3%) | -$36.11 M(+23.2%) |
Dec 2018 | -$29.32 M(-27.9%) | $846.00 K(-105.7%) | -$29.32 M(-34.0%) |
Sept 2018 | - | -$14.81 M(+30.6%) | -$44.43 M(+6.8%) |
June 2018 | - | -$11.34 M(+181.9%) | -$41.60 M(+67.3%) |
Mar 2018 | - | -$4.02 M(-71.8%) | -$24.86 M(-38.9%) |
Dec 2017 | -$40.67 M(-21.8%) | -$14.27 M(+19.1%) | -$40.67 M(+24.1%) |
Sept 2017 | - | -$11.97 M(-321.8%) | -$32.78 M(-34.4%) |
June 2017 | - | $5.40 M(-127.2%) | -$49.98 M(-33.5%) |
Mar 2017 | - | -$19.83 M(+211.2%) | -$75.15 M(+44.5%) |
Dec 2016 | -$52.01 M(-56.4%) | -$6.37 M(-78.2%) | -$52.01 M(-27.0%) |
Sept 2016 | - | -$29.18 M(+47.6%) | -$71.27 M(-4.6%) |
June 2016 | - | -$19.77 M(-696.8%) | -$74.68 M(-14.7%) |
Mar 2016 | - | $3.31 M(-112.9%) | -$87.51 M(-26.7%) |
Dec 2015 | -$119.42 M(+27.9%) | -$25.64 M(-21.3%) | -$119.42 M(-11.8%) |
Sept 2015 | - | -$32.59 M(-0.0%) | -$135.35 M(+37.9%) |
June 2015 | - | -$32.60 M(+14.0%) | -$98.16 M(+5.6%) |
Mar 2015 | - | -$28.60 M(-31.2%) | -$92.96 M(-0.4%) |
Dec 2014 | -$93.37 M(+118.4%) | -$41.57 M(-1003.1%) | -$93.37 M(+124.4%) |
Sept 2014 | - | $4.60 M(-116.8%) | -$41.60 M(-32.6%) |
June 2014 | - | -$27.40 M(-5.5%) | -$61.75 M(+17.9%) |
Mar 2014 | - | -$29.00 M(-384.4%) | -$52.36 M(+22.5%) |
Dec 2013 | -$42.74 M(-57.8%) | $10.20 M(-165.6%) | -$42.74 M(-40.3%) |
Sept 2013 | - | -$15.54 M(-13.7%) | -$71.54 M(+0.5%) |
June 2013 | - | -$18.01 M(-7.1%) | -$71.19 M(-31.1%) |
Mar 2013 | - | -$19.38 M(+4.2%) | -$103.31 M(+1.9%) |
Dec 2012 | -$101.37 M(+62.6%) | -$18.60 M(+22.5%) | -$101.37 M(+10.5%) |
Sept 2012 | - | -$15.19 M(-69.7%) | -$91.74 M(-1.6%) |
June 2012 | - | -$50.14 M(+187.4%) | -$93.21 M(+55.2%) |
Mar 2012 | - | -$17.45 M(+94.6%) | -$60.07 M(-3.7%) |
Dec 2011 | -$62.36 M(-24.5%) | -$8.97 M(-46.2%) | -$62.36 M(-14.7%) |
Sept 2011 | - | -$16.66 M(-2.0%) | -$73.11 M(+6.0%) |
June 2011 | - | -$17.00 M(-13.9%) | -$68.97 M(-8.6%) |
Mar 2011 | - | -$19.73 M(+0.1%) | -$75.46 M(-8.7%) |
Dec 2010 | -$82.64 M(-13.4%) | -$19.72 M(+57.5%) | -$82.64 M(-8.5%) |
Sept 2010 | - | -$12.52 M(-46.7%) | -$90.30 M(-19.9%) |
June 2010 | - | -$23.48 M(-12.8%) | -$112.80 M(+5.1%) |
Mar 2010 | - | -$26.92 M(-1.7%) | -$107.35 M(+12.5%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2009 | -$95.39 M(-47.0%) | -$27.38 M(-21.8%) | -$95.39 M(-10.2%) |
Sept 2009 | - | -$35.02 M(+94.3%) | -$106.27 M(-9.0%) |
June 2009 | - | -$18.03 M(+20.4%) | -$116.84 M(-25.5%) |
Mar 2009 | - | -$14.97 M(-60.9%) | -$156.83 M(-12.9%) |
Dec 2008 | -$180.03 M(+30.4%) | -$38.25 M(-16.1%) | -$180.03 M(+0.4%) |
Sept 2008 | - | -$45.59 M(-21.4%) | -$179.34 M(-1.6%) |
June 2008 | - | -$58.02 M(+52.0%) | -$182.22 M(+21.4%) |
Mar 2008 | - | -$38.16 M(+1.6%) | -$150.16 M(+8.7%) |
Dec 2007 | -$138.11 M(+1.7%) | -$37.56 M(-22.5%) | -$138.11 M(+3.1%) |
Sept 2007 | - | -$48.47 M(+86.7%) | -$133.97 M(+17.8%) |
June 2007 | - | -$25.96 M(-0.6%) | -$113.69 M(+5.1%) |
Mar 2007 | - | -$26.11 M(-21.9%) | -$108.20 M(-19.3%) |
Dec 2006 | -$135.82 M(+32.5%) | -$33.42 M(+18.5%) | -$134.00 M(+12.3%) |
Sept 2006 | - | -$28.20 M(+37.7%) | -$119.28 M(+19.8%) |
June 2006 | - | -$20.47 M(-60.6%) | -$99.59 M(-13.6%) |
Mar 2006 | - | -$51.92 M(+177.7%) | -$115.29 M(+12.5%) |
Dec 2005 | -$102.50 M(-59.4%) | -$18.69 M(+119.8%) | -$102.50 M(-19.5%) |
Sept 2005 | - | -$8.50 M(-76.5%) | -$127.35 M(-17.2%) |
June 2005 | - | -$36.17 M(-7.6%) | -$153.75 M(-0.8%) |
Mar 2005 | - | -$39.13 M(-10.1%) | -$155.03 M(-38.6%) |
Dec 2004 | -$252.30 M(+94.0%) | -$43.54 M(+24.7%) | -$252.30 M(+2.8%) |
Sept 2004 | - | -$34.91 M(-6.8%) | -$245.43 M(+1.1%) |
June 2004 | - | -$37.46 M(-72.5%) | -$242.64 M(+2.8%) |
Mar 2004 | - | -$136.40 M(+272.0%) | -$235.96 M(+81.5%) |
Dec 2003 | -$130.03 M(+160.6%) | -$36.67 M(+14.2%) | -$130.03 M(+107.0%) |
Sept 2003 | - | -$32.12 M(+4.4%) | -$62.83 M(+2.8%) |
June 2003 | - | -$30.78 M(+1.0%) | -$61.10 M(+7.5%) |
Mar 2003 | - | -$30.47 M(-199.8%) | -$56.81 M(+13.8%) |
Dec 2002 | -$49.90 M(-37.8%) | $30.54 M(-200.5%) | -$49.90 M(-55.4%) |
Sept 2002 | - | -$30.39 M(+14.7%) | -$111.93 M(+8.8%) |
June 2002 | - | -$26.49 M(+12.4%) | -$102.88 M(+11.5%) |
Mar 2002 | - | -$23.56 M(-25.2%) | -$92.25 M(+14.9%) |
Dec 2001 | -$80.27 M(+54.6%) | -$31.49 M(+47.5%) | -$80.27 M(+25.8%) |
Sept 2001 | - | -$21.34 M(+34.5%) | -$63.83 M(+13.0%) |
June 2001 | - | -$15.87 M(+37.0%) | -$56.47 M(+8.1%) |
Mar 2001 | - | -$11.58 M(-23.0%) | -$52.25 M(+1.0%) |
Dec 2000 | -$51.93 M(+43.1%) | -$15.05 M(+7.6%) | -$51.74 M(+14.7%) |
Sept 2000 | - | -$13.98 M(+20.1%) | -$45.09 M(+9.7%) |
June 2000 | - | -$11.64 M(+5.2%) | -$41.11 M(+4.4%) |
Mar 2000 | - | -$11.07 M(+31.8%) | -$39.37 M(+8.2%) |
Dec 1999 | -$36.30 M(+45.2%) | -$8.40 M(-16.0%) | -$36.40 M(+1.1%) |
Sept 1999 | - | -$10.00 M(+1.0%) | -$36.00 M(+13.9%) |
June 1999 | - | -$9.90 M(+22.2%) | -$31.60 M(+17.5%) |
Mar 1999 | - | -$8.10 M(+1.3%) | -$26.90 M(+7.6%) |
Dec 1998 | -$25.00 M(+8.7%) | -$8.00 M(+42.9%) | -$25.00 M(-0.8%) |
Sept 1998 | - | -$5.60 M(+7.7%) | -$25.20 M(+5.4%) |
June 1998 | - | -$5.20 M(-16.1%) | -$23.90 M(+1.3%) |
Mar 1998 | - | -$6.20 M(-24.4%) | -$23.60 M(+2.6%) |
Dec 1997 | -$23.00 M(+65.5%) | -$8.20 M(+90.7%) | -$23.00 M(+55.4%) |
Sept 1997 | - | -$4.30 M(-12.2%) | -$14.80 M(+41.0%) |
June 1997 | - | -$4.90 M(-12.5%) | -$10.50 M(+87.5%) |
Mar 1997 | - | -$5.60 M | -$5.60 M |
Dec 1996 | -$13.90 M | - | - |
FAQ
- What is CTI BioPharma annual net profit?
- What is the all time high annual net income for CTI BioPharma?
- What is CTI BioPharma annual net income year-on-year change?
- What is CTI BioPharma quarterly net profit?
- What is the all time high quarterly net income for CTI BioPharma?
- What is CTI BioPharma quarterly net income year-on-year change?
- What is CTI BioPharma TTM net profit?
- What is the all time high TTM net income for CTI BioPharma?
- What is CTI BioPharma TTM net income year-on-year change?
What is CTI BioPharma annual net profit?
The current annual net income of CTIC is -$92.99 M
What is the all time high annual net income for CTI BioPharma?
CTI BioPharma all-time high annual net profit is -$13.90 M
What is CTI BioPharma annual net income year-on-year change?
Over the past year, CTIC annual net profit has changed by +$4.92 M (+5.02%)
What is CTI BioPharma quarterly net profit?
The current quarterly net income of CTIC is -$13.42 M
What is the all time high quarterly net income for CTI BioPharma?
CTI BioPharma all-time high quarterly net profit is $30.54 M
What is CTI BioPharma quarterly net income year-on-year change?
Over the past year, CTIC quarterly net profit has changed by +$23.75 M (+63.90%)
What is CTI BioPharma TTM net profit?
The current TTM net income of CTIC is -$69.24 M
What is the all time high TTM net income for CTI BioPharma?
CTI BioPharma all-time high TTM net profit is -$5.60 M
What is CTI BioPharma TTM net income year-on-year change?
Over the past year, CTIC TTM net profit has changed by +$48.58 M (+41.23%)